NG
LLY icon

Novem Group’s Eli Lilly LLY Stock Holding History

Novem Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.01M Sell
1,672
-41
-2% -$41.9K 0.2% 101
2026
Q1 		$1.58M Buy
1,713
+196
+13% +$199K 0.18% 101
2025
Q4 		$1.63M Sell
1,517
-982
-39% -$939K 0.19% 100
2025
Q3 		$1.91M Sell
2,499
-13
-0.5% -$9.67K 0.22% 89
2025
Q2 		$1.96M Buy
2,512
+938
+60% +$729K 0.25% 82
2025
Q1 		$1.3M Sell
1,574
-127
-7% -$106K 0.18% 97
2024
Q4 		$1.31M Buy
+1,701
New +$1.41M 0.19% 93

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
GIM
Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Novem Group's LLY Position: Q2 2026 in Review

Novem Group reduced its Eli Lilly (LLY) stake by 2.4% in Q2 2026, selling an estimated $41.9K and leaving 1,672 shares worth $2.01M. The position accounts for 0.2% of the portfolio, ranked #101.

Novem Group first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 2,000 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Novem Group held 1,672 shares of Eli Lilly worth $2.01M as of Q2 2026.
  • Novem Group sold 41 Eli Lilly shares in Q2 2026, an estimated $41.9K.
  • Eli Lilly made up 0.2% of Novem Group's portfolio in Q2 2026, its #101 holding.
  • Novem Group first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 2,000 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Novem Group's 13F filing for Q2 2026, filed 21 Jul 2026.